Results 171 to 180 of about 335,645 (315)
Case Report: Multifocal cerebral infarctions caused by cyanoacrylate glue embolization after gastric variceal injection. [PDF]
Mousa AH +10 more
europepmc +1 more source
Epigenetic reprogramming in hematopoietic stem and progenitor cells (HSPCs) and downstream myeloid cells, mediated by H3.3 downregulation and endogenous retroelement (ERE) overexpression, contributes to the progression of multiple sclerosis (MS). ABSTRACT Background Skewed myelopoiesis in the bone marrow has been identified as a key driver of multiple ...
Li‐Mei Xiao +6 more
wiley +1 more source
Building on strengths : a community-based approach
tag=1 data=Building on strengths : a community-based approach tag=2 data=Canada. Northwest Territories tag=6 data=^d ^mFEB ^y1990 tag=8 data=DEVELOPMENT tag=9 data=ECONOMIC DEVELOPMENT AND TOURISM%ECONOMIC STRATEGY tag=15 data ...
Canada. Northwest Territories
core
The Americas are not on track to end TB: tuberculosis incidence analysis under the 2025 WHO goals. [PDF]
Rodríguez-Pazmiño ÁS +6 more
europepmc +1 more source
ABSTRACT Objective To explore how cerebral hypoxia and Normal‐Appearing White Matter (NAWM) integrity affect MS lesion burden and clinical course. Methods Seventy‐nine MS patients, including 13 clinically isolated syndrome (CIS) patients and 66 relapsing–remitting multiple sclerosis (RRMS) patients, and 44 healthy controls (HCs) were recruited from ...
Xinli Wang +8 more
wiley +1 more source
Relief shown by hachures.Note: green = irrigable land; blue = timber land.Above title: Department of the Interior, U. S. Geological and Geographical survey of the territories, Second Division. J. W.
Thompson, A. H. (Almon Harris), 1839-1906. +2 more
core
Barriers and facilitators to the utilization of cancer screening services in two Arctic Indigenous communities in Canada. [PDF]
Kolahdooz F +14 more
europepmc +1 more source
Quantifying the Impact of Ocrelizumab on Paramagnetic Rim Lesions in Multiple Sclerosis
ABSTRACT Paramagnetic rim lesions (PRLs) are a subset of chronic active multiple sclerosis (MS) lesions marked by iron‐laden microglia and macrophages. Ocrelizumab, a monoclonal antibody targeting CD20+ B cells, suppresses acute MS activity, but its effect on PRLs remains unclear. In a longitudinal study of 29 ocrelizumab‐treated patients with at least
Kimberly H. Markowitz +9 more
wiley +1 more source

